Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis
NCT05637281 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188
Last updated 2023-02-17
Summary
Acute pancreatitis is a common critical disease of the digestive system. Accumulated data showed that overexpression of cyclooxygenase-2 (COX-2) in acute pancreatitis and experimental pancreatitis could be attenuated with COX-2 inhibitors. In recent years, it has been found that timely administration of indomethacin or diclofenac sodium to anus after ERCP can significantly reduce the incidence of AP after ERCP in patients at high risk of AP. The aim of this study was to evaluate the efficacy of rectal indomethacin in reducing the systemic inflammatory response syndrome (SIRS) score in AP patients.
Conditions
- Acute Pancreatitis
- Systemic Inflammatory Response Syndrome
Interventions
- DRUG
-
Indometacin
Besides the conventional treatment, indomethacin will be given to the patients in the convention + indomethacin group.
- OTHER
-
conventional treatment
All enrolled patients received conventional management according to AP guidelines of International Association of Pancreatology and the Chinese Society of Gastroenterology, including goal-directed fluid resuscitation, oxygen supply even mechanical ventilation, and nutritional support if necessary.
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-11
- Primary Completion
- 2023-12-11
- Completion
- 2023-12-11
Countries
- China
Study Locations
More Related Trials
-
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
NCT00001191 ·Status: COMPLETED ·Phase: PHASE2
-
Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole
NCT01281501 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Non-enteric Coated Enzymes Substitution on Pain in Patients With Chronic Pancreatitis
NCT05042284 ·Status: COMPLETED ·Phase: NA
-
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
NCT01757275 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
NCT00164931 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD
NCT02730533 ·Status: COMPLETED ·Phase: NA
-
Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
NCT00279123 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Acute Pancreatitis With Ketorolac
NCT02885441 ·Status: TERMINATED ·Phase: PHASE4
-
Esomeprazole to Reduce Organ Failure in Sepsis
NCT03452865 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy
NCT01142245 ·Status: COMPLETED ·Phase: PHASE3
-
Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU
NCT02290327 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding
NCT00153725 ·Status: COMPLETED ·Phase: NA
-
Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy
NCT03948477 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
NCT00731601 ·Status: COMPLETED ·Phase: PHASE4
-
Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients
NCT02157376 ·Status: COMPLETED ·Phase: PHASE3
-
HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study
NCT05930119 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage
NCT00524329 ·Status: COMPLETED
-
Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
NCT00683111 ·Status: COMPLETED ·Phase: PHASE4
-
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
NCT07312370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
NCT00881413 ·Status: WITHDRAWN ·Phase: PHASE4
-
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
NCT03362281 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
NCT00040495 ·Status: COMPLETED ·Phase: PHASE3
-
PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease
NCT06861478 ·Status: RECRUITING ·Phase: PHASE2
-
A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
NCT01275937 ·Status: UNKNOWN ·Phase: PHASE4